共查询到20条相似文献,搜索用时 62 毫秒
1.
2.
日本是目前世界上最大的农产品进口国之一,不仅国内动物卫生体系完善,而且高度重视进境动物及产品检疫工作。日本建立了以《家畜传染病预防法》为主的动物防疫法律法规体系,建立并应用了进口动物及产品风险分析、检疫准入、检疫监管等制度。本文概述了日本进境动物及其产品基本情况、检疫监管相关法律法规和检疫监管体系等内容,并基于此对比了中日两国进境动物检疫制度的区别,最终借鉴日本进境动物监管制度,提出了围绕“正面清单”发布禁令和解禁令,科学设定隔离检疫期限,强化海关部门与农业农村部门合作的建议,为我国进境动物检疫监管工作提供了借鉴。 相似文献
3.
4.
野生动物的检疫监管是保护野生动物,维护生物多样性,促进生态平衡的重要内容,也是有效防控人兽共患病,保障公共卫生安全的重要举措。本文梳理了《野生动物保护法》《动物防疫法》有关野生动物检疫监管的相关条款,分析了野生动物检疫范围、检疫规程、监督执法等内容,指出了当前野生动物监管存在检疫对象和检疫范围不一致,检疫规程覆盖动物种类有限,监督执法依据操作性不强等难题。提出应通过完善立法以禁止滥食野生动物,强化普法宣贯以明确食用野生动物风险,科学制定检疫规程,明确检疫主体等检疫,以期对优化野生动物检疫监管措施提供支持。 相似文献
5.
6.
7.
8.
9.
本文通过梳理野生动物检疫有关的法律法规,结合实际工作中野生动物检疫面临的检疫范围不明确、缺少野生动物检疫规程、野生动物持证流通难等问题,提出明确野生动物检疫范围、及时出台野生动物检疫规程、对野生动物检疫实行分类管理、建立健全野生动物检疫监管机制等建议,以期为当前《动物检疫管理办法》修订完善提供参考意见. 相似文献
10.
目前应用进口动物卫生标准来管控国门生物安全的国家极少。我国进境动物卫生标准体系建设尚属空白。新西兰是全球制定进境动物卫生标准最早最全的国家。本文研究了新西兰进境动物卫生标准体系的科学管理、核心内容和主要特征,进口许可、动物及安全要求、出口前隔离检疫、入境口岸检疫和隔离检疫清关、兽医证书和随动物同行的证单要求等构成标准的核心内容,标准有强制性、法定性和权威性、系统性、可操性、及时性、易获取等特征。在比较分析我国进境动物检疫监管特征及问题基础上,创新提出借鉴新西兰进境动物卫生标准体系,制订我国进境动物卫生标准的建议并明确其法律地位,阐述了我国进境动物标准的编制原则、体系构成、基本框架、核心内容和主要措施。 相似文献
11.
12.
13.
14.
高致病性禽流感免疫的管理环节 总被引:1,自引:0,他引:1
一 严管疫苗生产环节
兽用生物制品生产厂家多,品种较多,质量不一,免疫效果各异,特别是高致病性禽流感疫苗,由于生产时间较短,疫苗质量不够稳定,副作用较为严重,包装规格单一,技术服务滞后.严重地影响了高致病性禽流感的免疫效果。如有的厂家疫苗生产的批准文号和疫苗产品不相符。有的中试产品或有临时批准文号的疫苗,不按规定范围随意大面积推广,有的同一厂家生产的疫苗,不同批次质量不一,免疫效果差异较大。 相似文献
15.
16.
17.
Strategies for Using eFSH for Superovulating Mares 总被引:1,自引:0,他引:1
Patrick M. McCue DVM PhD Melissa Patten BS David Denniston PhD Jason E. Bruemmer PhD Edward L. Squires PhD 《Journal of Equine Veterinary Science》2008,28(2):91-96
The standard treatment for superovulation of mares is to administer equine follicle-stimulating hormone (eFSH) for 4 to 5 days to stimulate multiple follicles and human chorionic gonadotropin (hCG) to induce synchronous ovulations. Objectives of this study were: (1) to determine whether a short-term (3-day) eFSH treatment protocol would result in similar ovulation and embryo recovery rates compared with the standard eFSH protocol; (2) to determine the efficacy of a decreasing dose of eFSH (step-down protocol) on ovulation rate and embryo recovery; (3) to compare the efficacy of hCG and recombinant equine luteinizing hormone (reLH) for inducing ovulation in FSH-treated mares; and (4) to compare embryo recovery rates and embryo size when mares are flushed at 6.5 or 7.0 days after ovulation. Forty light-horse mares were used in 2005 (experiment 1) and 20 different mares were used in 2006 (experiment 2). In experiment 1, mares were randomly assigned to one of three treatment groups: (1) untreated controls, (2) standard eFSH treatment (12.5 mg intramuscularly twice daily), and (3) 3-day eFSH treatment. In experiment 2, mares were randomly assigned to one of four treatments: (1) untreated controls, (2) standard eFSH protocol, (3) 3-day eFSH treatment, and (4) step-down eFSH treatment (12.5 mg twice daily day 1, 8.0 mg twice daily day 2, 4.0 mg twice daily day 3). Within each treatment, mares were given either hCG (2,500 IU) or equine LH (750 mg, EquiPure LH; reLH) to induce synchronized ovulations. Embryo recovery was performed either 6.5 or 7.0 days after ovulation. In experiment 1, numbers of preovulatory follicles and ovulations were less for mares in the 3-day treatment group than the standard group, but were greater than for controls. Embryo recovery per flush was higher in the standard group (2.6) than the 3-day eFSH treatment (0.8) or control groups (0.8). In experiment 2, the number of preovulatory follicles and number of ovulations were greater in the standard and 3-day treatment groups than in control and step-down groups. The percent embryo recovery per ovulation and mean embryo grade were similar for all groups; however, the embryo recovery per flush was higher for mares in the standard treatment than controls (1.3 vs 0.6) but was similar to the 3-day (1.1) and step-down (0.8) treatments. Embryo recovery was similar for flushes performed on days 6.5 and 7.0 post-ovulation. The percentage of control mares ovulating within 48 hours in response to hCG or reLH was similar. In contrast, a higher percentage of eFSH-treated mares ovulated within 48 hours in response to reLH than hCG (92% vs 71%). In both years, the 3-day eFSH treatment protocol resulted in a greater number of preovulatory follicles and a greater number of ovulations than untreated controls. Unfortunately, the increased ovulation rate for mares administered eFSH for 3 days did not result in a greater number of embryos recovered per flush in either year. Use of a step-down eFSH treatment protocol resulted in fewer preovulatory follicles, fewer ovulations, and fewer embryos as compared with the standard eFSH treatment. In conclusion, the standard eFSH treatment resulted in a greater embryo recovery rate per cycle than either the 3-day or step-down treatment protocols. Recombinant equine LH was more effective than hCG in causing ovulation in eFSH-treated mares. 相似文献
18.
19.
Transgenic pigs for xenotransplantation for humans] 总被引:1,自引:0,他引:1
H Niemann 《DTW. Deutsche tier?rztliche Wochenschrift》1999,106(4):141-146
Transgenic livestock have been generated via microinjection of DNA-constructs into pronuclei of zygotes. However, efficiency is low and only 1-3% transgenic offspring are to be obtained. Integration of the transgene occurs at random and expression is independent from the number of integrated copies but can be affected by the integration site. To overcome the shortage of human organs, transgenic pigs have been generated that express human complement regulatory genes. This approach enables to overcome the hyperacute rejection response as shown by an average survival rate (40-90 days) of the immunosuppressed primate recipients receiving a heart from a transgenic pig. It is expected that transgenic pigs would be available as organ donors in the next 5-10 years. A major prerequisite, however, is the prevention of the potential transfer of pathogenic microorganisms, in particular porcine endogenous retroviruses (PERV). Improvements of the efficiency in the generation of transgenic pigs will be achieved by the use of genetically modified donor cells in nuclear transfer technology (cloning). 相似文献